MultiPlan (NYSE:MPLN) Announces Earnings Results

MultiPlan (NYSE:MPLN) announced its quarterly earnings data on Tuesday. The company reported ($5.14) EPS for the quarter, topping analysts’ consensus estimates of ($13.50) by $8.36, Zacks reports. MultiPlan had a negative return on equity of 12.14% and a negative net margin of 163.30%. MultiPlan updated its FY 2025 guidance to EPS.

MultiPlan Trading Down 37.0 %

MPLN traded down $10.82 during trading hours on Tuesday, hitting $18.38. 125,720 shares of the company’s stock were exchanged, compared to its average volume of 163,704. The company has a debt-to-equity ratio of 21.73, a quick ratio of 1.05 and a current ratio of 1.05. MultiPlan has a 12-month low of $4.80 and a 12-month high of $48.80. The stock has a market cap of $297.29 million, a price-to-earnings ratio of -0.19 and a beta of 0.13. The stock’s 50 day moving average price is $17.39.

Wall Street Analysts Forecast Growth

Separately, Citigroup raised their price objective on MultiPlan from $10.00 to $12.50 and gave the stock a “neutral” rating in a research report on Friday, January 10th.

About MultiPlan

MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services.